Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    23098325 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed New Combination Inhaler (FlutiForm HFA MDI 100/10 µg and 250/10 µg) in Patients With Asthma
Condition: Asthma
Intervention: Drug: Fluticasone propionate/formoterol fumarate

Indicates status has not been verified in more than two years